L. Marks, S. Young, S. Natarajan. MRI-ultrasound fusion for guidance of targeted prostate biopsy. „Curr Opin Urol”. 23 (1), s. 43–50, 2013. DOI: 10.1097/MOU.0b013e32835ad3ee. PMID: 23138468.
E.H. Hamoen, M. de Rooij, J.A. Witjes, J.O. Barentsz i inni. Use of the Prostate Imaging Reporting and Data System (PI-RADS) for Prostate Cancer Detection with Multiparametric Magnetic Resonance Imaging: A Diagnostic Meta-analysis. „Eur Urol”. 67 (6), s. 1112–1121, 2015. DOI: 10.1016/j.eururo.2014.10.033. PMID: 25466942.
J.O. Barentsz, J.C. Weinreb, S. Verma, H.C. Thoeny i inni. Synopsis of the PI-RADS v2 Guidelines for Multiparametric Prostate Magnetic Resonance Imaging and Recommendations for Use. „Eur Urol”. 69 (1), s. 41–49, 2016. DOI: 10.1016/j.eururo.2015.08.038. PMID: 26361169.
T. Hambrock, C. Hoeks, C. Hulsbergen-van de Kaa, T. Scheenen i inni. Prospective assessment of prostate cancer aggressiveness using 3-T diffusion-weighted magnetic resonance imaging-guided biopsies versus a systematic 10-core transrectal ultrasound prostate biopsy cohort. „Eur Urol”. 61 (1), s. 177–184, 2012. DOI: 10.1016/j.eururo.2011.08.042. PMID: 21924545.
nih.gov
ncbi.nlm.nih.gov
L. Marks, S. Young, S. Natarajan. MRI-ultrasound fusion for guidance of targeted prostate biopsy. „Curr Opin Urol”. 23 (1), s. 43–50, 2013. DOI: 10.1097/MOU.0b013e32835ad3ee. PMID: 23138468.
E.H. Hamoen, M. de Rooij, J.A. Witjes, J.O. Barentsz i inni. Use of the Prostate Imaging Reporting and Data System (PI-RADS) for Prostate Cancer Detection with Multiparametric Magnetic Resonance Imaging: A Diagnostic Meta-analysis. „Eur Urol”. 67 (6), s. 1112–1121, 2015. DOI: 10.1016/j.eururo.2014.10.033. PMID: 25466942.
J.O. Barentsz, J.C. Weinreb, S. Verma, H.C. Thoeny i inni. Synopsis of the PI-RADS v2 Guidelines for Multiparametric Prostate Magnetic Resonance Imaging and Recommendations for Use. „Eur Urol”. 69 (1), s. 41–49, 2016. DOI: 10.1016/j.eururo.2015.08.038. PMID: 26361169.
T. Hambrock, C. Hoeks, C. Hulsbergen-van de Kaa, T. Scheenen i inni. Prospective assessment of prostate cancer aggressiveness using 3-T diffusion-weighted magnetic resonance imaging-guided biopsies versus a systematic 10-core transrectal ultrasound prostate biopsy cohort. „Eur Urol”. 61 (1), s. 177–184, 2012. DOI: 10.1016/j.eururo.2011.08.042. PMID: 21924545.